BFM
DVAX

Boothbay Fund Management’s Dynavax Technologies DVAX Stock Holding History

Boothbay Fund Management’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-434
Closed -$538K – 715
2018
Q3 		$538K Buy
+434
New +$5.87K 0.05% 340

Other funds holding DVAX

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCPEMI
Bain Capital Public Equity Management II Boston, Massachusetts $62.1M AUM 25.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Boothbay Fund Management's DVAX Position: Q1 2020 in Review

Boothbay Fund Management sold out of Dynavax Technologies (DVAX) in Q1 2020, closing a stake of 20,000 shares — an estimated $114K sold.

Boothbay Fund Management first reported a position in DVAX in Q3 2019 and held it in 2 quarters. The position peaked at $144K in Q3 2019. 113 funds tracked by Wall St. Rank hold DVAX as of Q1 2020.

  • Boothbay Fund Management reported no remaining Dynavax Technologies position as of Q1 2020 after selling out during the quarter.
  • Boothbay Fund Management sold 20,000 Dynavax Technologies shares in Q1 2020, an estimated $114K.
  • Boothbay Fund Management first reported a position in Dynavax Technologies in Q3 2019 and held it in 2 quarters.
  • Boothbay Fund Management's Dynavax Technologies position peaked at $144K in Q3 2019.
  • 113 funds tracked by Wall St. Rank held Dynavax Technologies as of Q1 2020.

Based on Boothbay Fund Management's 13F filing for Q1 2020, filed 15 May 2020.